Recherche - Université de Picardie Jules Verne Accéder directement au contenu

Filtrer vos résultats

5 Résultats
Structure : Identifiant HAL de la structure : 2627

An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19

Florence Ader , Nathan Peiffer-Smadja , Julien Poissy , Maude Bouscambert-Duchamp , Drifa Belhadi , et al.
Clinical Microbiology and Infection, 2021, 27 (12), pp.1826-1837. ⟨10.1016/j.cmi.2021.05.020⟩
Article dans une revue hal-03364426v1

Effectiveness of golimumab intensification in ulcerative colitis: A multicentric prospective study

Mathurin Fumery , Stéphane Nancey , Jérôme Filippi , Romain Altwegg , Xavier Hébuterne , et al.
Alimentary Pharmacology & Therapeutics (Suppl), 2023, ⟨10.1111/apt.17421⟩
Article dans une revue hal-04012020v1

Cancer-associated thrombosis: how many patients seen in clinical practice would be eligible to a randomized controlled trial?

B. Petit , S. Soudet , G. Poenou , E. Zarrat , T. Machuron , et al.
Thrombosis Research, 2022, 213 (2), pp.S30
Article dans une revue hal-03679317v1

Cancer Associated Thrombosis:how many lung cancer patients seen in clinical practice would be eligible to a DOAC randomized controlled trial?

B Petit , V Mismetti , S Soudet , G Poenou , E Zarrat , et al.
The European respiratory journal. Supplement., 2022, 60 (66), pp.1652. ⟨10.1183/13993003.congress-2022.1652⟩
Article dans une revue hal-04021110v1
Image document

Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

Paul Bastard , Adrian Gervais , Tom Le Voyer , Jeremie Rosain , Quentin Philippot , et al.
Science Immunology, 2021, 6 (62), pp.eabl4340. ⟨10.1126/sciimmunol.abl4340⟩
Article dans une revue hal-03358792v1